Light-based drug delivery for sarcoma treatment
Part of Cancer clinical trials.
This trial tests a new light-based drug delivery system to treat sarcomas. It looks at how well this platform works during surgery or biopsy for patients with soft tissue or bone sarcomas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 85 years old.
- You have a soft tissue sarcoma or bone sarcoma (including osteosarcoma).
- You are having surgery or a biopsy for the sarcoma.
- You may have had or be currently getting chemotherapy, targeted therapy, radiation, or a mix of these.
- If you are being treated at the Istituto Ortopedico Rizzoli, you will need to sign two consent forms. At IRST, adult patients only need to sign one.
- You do not have multiple primary tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20093 combined with other treatments for people with advanced bone or soft tissue sarcoma. It aims to find safe and effective combinations for those who haven't responded to standard treatments.
This trial tests a combination of targeted therapy, chemotherapy, and radiation for advanced soft tissue sarcoma that has not responded to standard treatment. It aims to see if the combination can help patients live longer or shrink their tumors.
This trial tests a personalized (“adaptive”) radiation plan before surgery for high-grade soft-tissue sarcoma that can be removed. It may help shrink the tumor and improve how well surgery can treat the cancer.
This trial tests a new blood-test technology to find and study cancer cells in people with advanced soft tissue sarcoma. It aims to improve how we track the disease and guide treatment decisions.
This trial studies a high-dose, shortened course of proton beam radiation for people with soft tissue sarcoma that cannot be removed by surgery. It aims to improve tumor control while reducing side effects.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
Hear when a new Bone and Soft Tissue Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.